Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy

Shiow Ching Shun, Jeng Fong Chiou, Yeur H. Lai, Po J. Yu, Lin L. Wei, Jo Ting Tsai, Chung Y. Kao, Ya L. Hsiao

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose: Due to the increasing use of stereotactic radiotherapy (SRT) in treating advanced liver cancer patients, the purpose of this longitudinal study was to explore the changes and factors related to quality of life (QOL) in patients receiving SRT treatment. Materials and methods: Liver cancer patients receiving SRT in northern Taiwan were recruited. The patients were followed up during the baseline pre-SRT and the first 6 weeks of SRT (T0 to T6) in assessing functional status and symptom severity, while depression, selected laboratory data, and QOL were assessed every 3 weeks (T0, T3, and T6). Generalized estimating equations (GEE) analysis was used to explore the significant factors related to the change in QOL. Results: Ninety-nine patients with advanced liver cancer completed seven interviews. The results showed that QOL during SRT was moderate and relatively stable. Performance functional status, depression, the level of albumin, and overall symptom severity were significantly associated with changes in QOL. A further analysis of the relationships between individual symptom severity and QOL revealed that fatigue, lack of appetite, pain, and nausea were the symptoms most affecting QOL across the 6 weeks of SRT. Conclusion: Liver cancer patients had stable and moderate levels of QOL during SRT. Factors related to QOL across the 6 weeks were multi-dimensional. Both overall symptom severity and selected individual symptoms were important to patients' QOL. These factors should all be carefully assessed and clinically treated to enhance liver cancer patients' QOL during SRT.

Original languageEnglish
Pages (from-to)1059-1065
Number of pages7
JournalSupportive Care in Cancer
Volume16
Issue number9
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Liver Neoplasms
Radiotherapy
Quality of Life
Depression
Appetite
Taiwan
Nausea
Fatigue
Longitudinal Studies
Albumins
Interviews
Pain

Keywords

  • Depression
  • Hepatocellular carcinoma
  • Quality of life
  • Stereotactic radiation therapy
  • Symptom severity

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Cite this

Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. / Shun, Shiow Ching; Chiou, Jeng Fong; Lai, Yeur H.; Yu, Po J.; Wei, Lin L.; Tsai, Jo Ting; Kao, Chung Y.; Hsiao, Ya L.

In: Supportive Care in Cancer, Vol. 16, No. 9, 09.2008, p. 1059-1065.

Research output: Contribution to journalArticle

Shun, Shiow Ching ; Chiou, Jeng Fong ; Lai, Yeur H. ; Yu, Po J. ; Wei, Lin L. ; Tsai, Jo Ting ; Kao, Chung Y. ; Hsiao, Ya L. / Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. In: Supportive Care in Cancer. 2008 ; Vol. 16, No. 9. pp. 1059-1065.
@article{947e487767684a95b7a6038960f08829,
title = "Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy",
abstract = "Purpose: Due to the increasing use of stereotactic radiotherapy (SRT) in treating advanced liver cancer patients, the purpose of this longitudinal study was to explore the changes and factors related to quality of life (QOL) in patients receiving SRT treatment. Materials and methods: Liver cancer patients receiving SRT in northern Taiwan were recruited. The patients were followed up during the baseline pre-SRT and the first 6 weeks of SRT (T0 to T6) in assessing functional status and symptom severity, while depression, selected laboratory data, and QOL were assessed every 3 weeks (T0, T3, and T6). Generalized estimating equations (GEE) analysis was used to explore the significant factors related to the change in QOL. Results: Ninety-nine patients with advanced liver cancer completed seven interviews. The results showed that QOL during SRT was moderate and relatively stable. Performance functional status, depression, the level of albumin, and overall symptom severity were significantly associated with changes in QOL. A further analysis of the relationships between individual symptom severity and QOL revealed that fatigue, lack of appetite, pain, and nausea were the symptoms most affecting QOL across the 6 weeks of SRT. Conclusion: Liver cancer patients had stable and moderate levels of QOL during SRT. Factors related to QOL across the 6 weeks were multi-dimensional. Both overall symptom severity and selected individual symptoms were important to patients' QOL. These factors should all be carefully assessed and clinically treated to enhance liver cancer patients' QOL during SRT.",
keywords = "Depression, Hepatocellular carcinoma, Quality of life, Stereotactic radiation therapy, Symptom severity",
author = "Shun, {Shiow Ching} and Chiou, {Jeng Fong} and Lai, {Yeur H.} and Yu, {Po J.} and Wei, {Lin L.} and Tsai, {Jo Ting} and Kao, {Chung Y.} and Hsiao, {Ya L.}",
year = "2008",
month = "9",
doi = "10.1007/s00520-007-0384-y",
language = "English",
volume = "16",
pages = "1059--1065",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy

AU - Shun, Shiow Ching

AU - Chiou, Jeng Fong

AU - Lai, Yeur H.

AU - Yu, Po J.

AU - Wei, Lin L.

AU - Tsai, Jo Ting

AU - Kao, Chung Y.

AU - Hsiao, Ya L.

PY - 2008/9

Y1 - 2008/9

N2 - Purpose: Due to the increasing use of stereotactic radiotherapy (SRT) in treating advanced liver cancer patients, the purpose of this longitudinal study was to explore the changes and factors related to quality of life (QOL) in patients receiving SRT treatment. Materials and methods: Liver cancer patients receiving SRT in northern Taiwan were recruited. The patients were followed up during the baseline pre-SRT and the first 6 weeks of SRT (T0 to T6) in assessing functional status and symptom severity, while depression, selected laboratory data, and QOL were assessed every 3 weeks (T0, T3, and T6). Generalized estimating equations (GEE) analysis was used to explore the significant factors related to the change in QOL. Results: Ninety-nine patients with advanced liver cancer completed seven interviews. The results showed that QOL during SRT was moderate and relatively stable. Performance functional status, depression, the level of albumin, and overall symptom severity were significantly associated with changes in QOL. A further analysis of the relationships between individual symptom severity and QOL revealed that fatigue, lack of appetite, pain, and nausea were the symptoms most affecting QOL across the 6 weeks of SRT. Conclusion: Liver cancer patients had stable and moderate levels of QOL during SRT. Factors related to QOL across the 6 weeks were multi-dimensional. Both overall symptom severity and selected individual symptoms were important to patients' QOL. These factors should all be carefully assessed and clinically treated to enhance liver cancer patients' QOL during SRT.

AB - Purpose: Due to the increasing use of stereotactic radiotherapy (SRT) in treating advanced liver cancer patients, the purpose of this longitudinal study was to explore the changes and factors related to quality of life (QOL) in patients receiving SRT treatment. Materials and methods: Liver cancer patients receiving SRT in northern Taiwan were recruited. The patients were followed up during the baseline pre-SRT and the first 6 weeks of SRT (T0 to T6) in assessing functional status and symptom severity, while depression, selected laboratory data, and QOL were assessed every 3 weeks (T0, T3, and T6). Generalized estimating equations (GEE) analysis was used to explore the significant factors related to the change in QOL. Results: Ninety-nine patients with advanced liver cancer completed seven interviews. The results showed that QOL during SRT was moderate and relatively stable. Performance functional status, depression, the level of albumin, and overall symptom severity were significantly associated with changes in QOL. A further analysis of the relationships between individual symptom severity and QOL revealed that fatigue, lack of appetite, pain, and nausea were the symptoms most affecting QOL across the 6 weeks of SRT. Conclusion: Liver cancer patients had stable and moderate levels of QOL during SRT. Factors related to QOL across the 6 weeks were multi-dimensional. Both overall symptom severity and selected individual symptoms were important to patients' QOL. These factors should all be carefully assessed and clinically treated to enhance liver cancer patients' QOL during SRT.

KW - Depression

KW - Hepatocellular carcinoma

KW - Quality of life

KW - Stereotactic radiation therapy

KW - Symptom severity

UR - http://www.scopus.com/inward/record.url?scp=49349098532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49349098532&partnerID=8YFLogxK

U2 - 10.1007/s00520-007-0384-y

DO - 10.1007/s00520-007-0384-y

M3 - Article

C2 - 18197433

AN - SCOPUS:49349098532

VL - 16

SP - 1059

EP - 1065

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 9

ER -